Skip to main content
Neurology logoLink to Neurology
. 2020 Mar 10;94(10):459. doi: 10.1212/WNL.0000000000008715

Genetic determinants of disease severity in the myotonic dystrophy type 1 OPTIMISTIC cohort

PMCID: PMC7978479  PMID: 32047069

In the article “Genetic determinants of disease severity in the myotonic dystrophy type 1 OPTIMISTIC cohort” by Cumming et al.,1 the study funding section should have read “Study funded by European Union's Seventh Framework Programme (FP7/2007–2013) under grant agreement number 305697 (the OPTIMISTIC project), the Wellcome Centre for Mitochondrial Research (ref 203105/Z/16/Z)), and donations to the DGM group from the Myotonic Dystrophy Support Group. The funders had no role in the study design, data collection, analysis, interpretation of data, writing the report, or decisions regarding when to submit publications.” The authors regret the error.

Reference

  • 1.Cumming SA, Jimenez-Moreno C, Okkersen K, et al. Genetic determinants of disease severity in the myotonic dystrophy type 1 OPTIMISTIC cohort. Neurology 2019;93:e995–e1009. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Neurology are provided here courtesy of American Academy of Neurology

RESOURCES